Response to trastuzumab by HER2 expressing breast tumour xenografts is accompanied by decreased Hexokinase II, glut1 and [18F]-FDG incorporation and changes in 31P-NMR-detectable phosphomonoesters

导出原文传递

翻译打印收藏纠错

作者： Smith,T.A.D. ^[1] ; Appleyard,M.V.C.L. ^[2] ; Sharp,S. ; Fleming,I.N. ; Murray,K. ; Thompson,A.M.

作者单位： Division of Applied Medicine, School of Medicine and Dentistry, University of Aberdeen ^[1] Dundee Cancer Centre, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY ^[2]

关键词 31P-NMR [18F]FDG Hexokinase Trastuzumab Xenograft

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cancer Chemotherapy and Pharmacology

2013年71卷2期

473-480页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Response to trastuzumab by HER2 expressing breast tumour xenografts is accompanied by decreased Hexokinase II, glut1 and [18F]-FDG incorporation and changes in 31P-NMR-detectable phosphomonoesters

Cancer Chemotherapy and Pharmacology

相似文献

Cancer Chemotherapy and Pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Response to trastuzumab by HER2 expressing breast tumour xenografts is accompanied by decreased Hexokinase II, glut1 and [18F]-FDG incorporation and changes in 31P-NMR-detectable phosphomonoesters

Cancer Chemotherapy and Pharmacology

相似文献

Cancer Chemotherapy and Pharmacology

相关期刊

检索历史清除